COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Household Knowledge of Iodized Salt and Iodine Content of Dietary Salt in Morocco Further 25 Years of Universal Salt Iodization: A National Cross-Sectional Study
- Association between 24-hour urinary sodium and iodine in a Beninese population
- Impact of Red Cabbage and Red Onion Anthocyanin Supplementation on Lipid Profiles in Amateur Soccer Players: A Randomized Placebo-Controlled Study
- Effect of acute supplementation of hibiscus-ginger drink on university athletes’ aerobic power and blood lactate
- Sports supplements: use, knowledge, and risks for Algerian athletes
- Assessment of energy and nutrient intake adequacy and dietary diversity of pregnant women in Abidjan
- Supplementation species effect on the phenolic content and biological bioactivities of the decocted green tea
- Nutritional and Bioactive Profile of Gitumon: An Indonesian Traditional Herbal Beverage
- Impact of carob (Ceratonia Ciliqua L) pulp flour supplementation on probiotic viability, milk fermentation and antioxidant capacity during yogurt storage
- The impact of probiotic supplementation on depressive symptoms: a systematic review of clinical trials
You may also start an advanced similarity search for this article.
NAJFNR is licensed under